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Beta-Adrenergic Blockade Reduces Myocardial Injury During
Experimental Cardiopulmonary Resuscitation
ROY V. DITCHEY, MD, FACC, ANA
RUBIO-PEREZ, MD, BRYAN K. SLINKER, DVM, Pt1D
Burlington, Vermont
Objntives. We attempted to determine the effects of beta-
adrenergic blockade during cardiopulmonary resuscitation (CPR)
on defibrillation rates and pustresuscitation left ventricular func-
lion.
Background. The results , if previous studies suggest that pro-
pranolol administration can both reduce myocardial oxygen re-
quireruents and increase coronary perfusion pressure during
CPR
Illetbods. Left ventricular pressure and segment length were
measured before and after S min of CPR In 22 dogs either given
epinephrine (0.015 mg/kg body weight at the onset and after
4 min) or pretreated with N:aprarulol (2 mg/kg) and given
epinepbrine during CPR
Results. Despite identical epinephrine doses, coronary perfu-
sion pressure during CPR was higher In the epinephrine plus
propranolol group (p < 0.05), and defibrillation was successful in
9 of I 1 dogs given both epinephrine and propranolol versus 6 of I I
Closed chest cardiopulmonary resuscitation (CPR) does not
produce enough coronary blood flow to maintain myocardial
oxygenation during ventricular fibrillation (1,2) . This is the
result of both low levels of coronary flow (1-9) and high
myocardial oxygen requirements as a result of intense sympa-
thetic stimulation of the heart (10). Although epinephrine and
other vasoconstrictors increase coronary blood flow during
CPR (2,8,11-13) . such agents fail to improve (and may worsen)
the imbalance between myocardial oxygen supply and demand
(2,14), presumably because of direct positive inotropic effects
and enhanced delivery of endogenous catecholamines to the
heart. In contrast, we recently found that myocardial oxygen-
ation during CPR can be improved by administering a combi-
nation of phenylephrint and propranolol (14) .
Because of these considerations, we hypothesized that
beta-adrenergic blockade can reduce myocardial ischemic in-
jury during CPR and thereby increase the likelihood of suc-
cessful resuscitation and improve postresuscitation left ventric-
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dogs given epinephrine alone (p = NS). Peak and developed left
ventricular pressures, left ventricular end-diastolic pressure and
the peak rate of left ventricular pressure development (+dP/dt)
did not differ between study groups when measured either 5 or
15 min after successful defibrillation . However, when survivors in
the epinephrine group were given propranolol after CPR to
eliminate compensatory sympathetic stimulation, left ventricular
developed pressure and peak +dP/dt were lower (p < 0 .05)
despite trends toward higher left ventricular end-diastolic pres-
sures and normalized end-diastolic segment lengths compared
with dogs given propranolol before CPR .
Conclusions. These findings suggest that beta-adrenergic block-
ade reduces myocardial injury during CPR without decreasing the
likelihood of successful defibrillation or compromising spontaneous
postresuscitation left ventricular function .
(J Am Coll Cardiol 1994:24:804-12)
ular function . Because pharmaco!ogic vasoconstriction with
epinephrine increases coronary blood flow during CPR, we
approached the problem by comparing defibrillation rates and
indexes of ventricular performance in two groups of dogs
either given conventional doses of epinephrine or pretreated
with propranolol and giver the same doses of epinephrine
during CPR. This study design ensured that both groups
received comparable doses of vasoconstrictiog agents . Pro-
pranolol was administered under prearrest conditions (i .e .,
before induction of ventricular fibrillation) rather than during
CPR to allow a comparison of functional indexes in the
presence of similar levels of sympathetic stimulation before
and after CPR .
Methods
Study animals and instrumentation . Studies were per-
formed in 22 random-source dogs weighing an average of
20.7 kg (range 17.3 to 24.5). The dogs were anesthetized with
morphine sulfate (2 mg/kg body weight) and alpha-chloralose
(10() mg/kg), intubated and mechanically ventilated with a
device that mixed room air with 100% oxygen by a Venturi
effect. A left lateral thoracotomy was performed, and the
pericardium was opened . A pair of piezoelectric crystals was
impl.,nted -1 to 1 .5 cm apart in the midanterior left ventric-
ular free wall, parallel to the expected midwall fiber axis . Cuff
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occluders were placed around both the superior and inferior
vcnae cavae, and internal defibrillator pads (Cardiac Pacemak-
ers, Inc .) appropriate in size `or canine hearts were sutured
over the right ventricular and posterolateral left ventricular
free wails. The wires from the piezoelectric crystals, the cables
from the defibrillator pads and the inflation tubes from the cuff
occluders were exteriorized through small incisions in the chest
wall. The pericardium was loosely reapproximated, the chest
was closed, and the dogs were secured in a supine position .
High fidelity, microniationicter-tipped catheters (Millar Instru-
ment), each with a fluid-filled lumen for recording pressures,
were inserted through a femoral artery and an external jugular
vein and positioned in the left ventricle and in the high right
atrium, respectively . Catheter position was confirmed by ap-
propriate pressure recordings and fluoroscopically . The lumen
of each high fidelity catheter was connected to a Gould P23 XI_
pressure transducer with zero reference set at approximately
the midehest level. Heparin (30M to 5,000 U) was adminis-
tered intravenously to retard clot formation .
After hisirumenmlion, ventilatory variables were adjusted
to maintain arterial pH between 7.35 and 7.45 and arterial
partial pressure of carbon dioxide (Paso,) between 35 and
45 turn Hg. Sodium bicarbonate solution was administered intra-
venously when necessary . In addition, atropine (0 .05 mg/kg) was
administered intravenously to reduce variability in heart rate
during subsequent pressure and segment length measurements,
and normal saline solution was administered in a volume suffi-
cient to increase left ventricular end-diastolic pressure to
-5 mm Hg. This was done to reduce variability in baseline
intravascular volume between animals.
Pressure and segment length recordings. Ea61 set of pres-
sure and segment length recordings before and after CPR was
made in the following manner. First, left ventricular pressurei
and segment length were recorded throughout several respira-
tory cycles . Ventilation then was suspended temporarily at
end-expiration, and left ventricular pressure and segment
length were recorded as pressure was reduced by vena caval
occlusion. The caval occlusions then were released, ventilation
was resumed, and the left ventricular catheter was pulled back
into the aorta. When pressures appeared stable, aortic and
right atria] pressures were recorded . After an initial set of
prearrest pressure and segment length measurements, I I dogs
were given propranolol (2 mg/kg) through the right atrial
catheter. A second set of prearrest measurements then was
obtained in all animals. Ventricular fibrillation then was in-
duced by applying a low voltage alternating current to the
internal defibrillator pads. The current was discontinued after
a decrease in aortic pressure and loss of normal pressure
waveforms were observed . In some cases, the current had to be
applied more than once because of spontaneous recovery .
Anteroposterior chest compression was initiated immediately
after the onset of ventricular fibrillation was confirmed . The
chest was compressed -80 times/min with a constant force
estimated to be >140 lb and a compression duration equal to
-50% of each cycle with a modified, pneumatic chest com-
pression device (model X1004 LifeAid Cardiopulmonary Re-
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suscitator, Michigan Instruments)
. Movement of the compres-
sion piston was recorded continuously with a displacement
transducer
. The release phase of each cycle was prolonged
every fifth compression to allow synchronized lung inflation to
a peak inspiratory pressure of 10 cm of water . All dogs were
given epinephrine (0 .015 mg/kg) as a bolus through the right
atrial catheter at the onset of CPR and again after approxi-
mately 4 min of CPR . An arterial blood sample was obtained
for gas analysis during the fifth minute of CPR .
After precisely 5 ruin of CPR, defibrillation was attempted
by applying sequential shocks of 20, 30, 40, 50 and 100 J (as
needed) to the internal defibrillator pads using a calibrated
PhysioControl defibrillator. If an organized rhythm and spon-
taneous circulation were not restored after the 100-J shock,
defibrillation was considered unsuccessful . An arterial blood
gas sample was obtained, and pressures and segment lengths
were recorded in survivors 5 min and again 15 min after the
end of CPR. The control animals then were given propranolol
(2 mg/kg) through the right atrial catheter to eliminate the
effects of sympathetic stimulation of the heart . A final set of
pressure and segment length measurements was obtained in all
animals -20 min after the end of CPR (the actual time
intervals varied slightly) .
Pressures and other signals were recorded using a Sensor-
medic Dynagraph 11612 recorder . These recordings were used
only for monitoring during the study . Data also were digitized
on-line at a sampling frequency of 5111 Hz using a POP-11/73
microcomputer (Digital Equipment Corp .). Pressures and
segment lengths were analyzed using specially designed soft-
ware . To correct for baseline offset, high fidelity pressures
before and after CPR were corrected for any differences
between high fidelity and standard mean right atrial or aortic
pressures, similarly, high fidelity pressures during CPR were
corrected for any differences between high fidelity and stan-
dard mean aortic or right atrial pressures recorded immedi-
ately before induction of ventricular fibrillation .
Pressures before and after CPR were averaged over four
respiratory cycles . In addition . all individual cardiac cycles
during vena caval occlusion were analyzed, ending with either
the cycle containing the nadir in left ventricular peak systolic
pressure or the last cycle before the occurrence of a premature
ventricular heat . These data were used to generate end-
diastolic pressure-segment length relations and to express the
peak rate of left ventricular pressure development (+dP/dt) as
a function of end-diastolic segment length under each condi-
tion (15) . We also had intended to use these data to generate
left ventricular end-systolic pressure-segment length relations
under each condition, but on the basis of inspection of
individual pressure-segment length loops, we concluded that
the shape of the systolic portion of the loops precluded
meaningful analysis in the majority of cases, particularly after
resuscitation . Therefore, only end-diastolic segment lengths
were analyzed . The release phase of each chest compression
cycle during CPR was identified as the interval between the
peak rate of aortic pressure decrease after the release of chest
compression and 10% of the peak rate of pressure increase
M06
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Table 1 . Prearrest Measurements in 22 Study Dogs
°p 0,05 versus control group, tp < (( .05 versus hasdine. Data presented arc mean value SD. AoP ascending aortic pressure ; +dPldt (-dPldt) = positive
(negative) first derivative of left ventricular pressure
; LVEDP - left ventricular end-diastolic pressure ; LVSP - left ventricular systolic pressure
; Normalized EDSI .
left ventricular endadiastolie segment length, normalized with resivet to baseline values; RAP == right atrdal pressure .
during the subsequent compression . Peak and mean pressures
and the mean release phase aortic-right atrial pressure differ-
ence were determined for each chest compression cycle
throughout the 5-min period of CPR .
Statistical analysis . Data are expressed as mean value -±-
SD, unless otherwise stated . Mean release phase aortic-right
atrial pressure differences as a function of time during CPR
were compared between the two study groups by analysis of
covariance with time as the covariatc . Differences between the
two study groups and between the two prearrest sets of
measurements in the propranolol group were compared using
two-way analysis of variance (ANOVA) with repeated mea-
sures over time (i.e ., the first versus the second prearrest
condition). Similarly, differences between and within study
groups in successfully defibrillated dogs were compared using
a two-way repeated measures ANOVA with repeated mea-
sures over time (including the second prearrest and the three
pustdefihrillation conditions) . In this case, the ANOVA com-
putations were corrected for unequal sample sizes (16,17) .
When the interaction effect was significant at p < 0,10,
selected multiple comparisons were made with Bonferroni-
corrected t tests to test for pairwise differences of interest
(again corrected for unequal sample sizes [161) . Four compar-
isons were made across time: the three postdehhrillation
conditions were compared with prearrest measurements in the
propranolol' group, and the 20- and 15-min postdefibrillation
conditions were compared in the control group. In addition,
the control and propranolol groups were compared under each
postdefibrillation condition. A similar analysis was used to
compare the prearrest, CPR and three postdefihrillation sets of
hematoerit values and blood gases
; when the interaction effect
was significant, the control and propranolol groups were
compared under each condition using Bonferroni-corrected t
tests
. Finally, the relation between peak +dP/dt and normal-
ized end-diastolic segment length was computed under each
condition using a linear regression analysis that included
dummy variables to account for the different subjects (17) . All
ANOVA and covariance were computed using SAS procedure
GLM (18) .
Regression analyses were computed using
MINITAB (19).
These studies conform to the "Position of the American
Heart Association on Research Animal Use" adopted by the
Association in November 1984 .
Results
Prearrest measurements . Pressure and segment length
measurements made before induction of ventricular fibrillation
are summarized in Table 1 . By chance, the group subsequently
given propranolol had a higher mean initial heart rate than the
control group . There were no significant differences between
the two study groups with regard to left ventricular loading
conditions or indexes of left ventricular performance under
baseline conditions, although there was a trend toward a
higher mean left ventricular end-diastolic pressure in the
control group. As expected, propranolol administration caused
a significant decrement in left ventricular function before
induction of ventricular fibrillation, as evidenced by significant
decreases in peak and developed left ventricular systolic pres-
sures and the peak rate of left ventricular pressure develop-
ment (+dP/dt), despite significant increases in left ventricular
end-diastolic pressure and normalized end-diastolic segment
length ("Table 1) .
Coronary perfusion pressure . The mean release phase
aortic-right atrial pressure difference in each study group is
shown as a function of time during CPR in Figure 1 . This
estimate of coronary perfusion pressure was significantly
higher in the propranolol group than in the control group (p <
0.05) . Figure 2 demonstrates that this difference was due to a
higher average aortic pressure rather than a lower average
right atrial pressure during CPR in the propranolol group .
Defibrillation rates. Defibrillation was successful in 9 of I I
dogs in the propranolol group and in 6 of 11 dogs in the control
group (p = NS)
. The median number of electrical shocks
required for initial defibrillation in survivors was one in the
propranolol group and two in the control group . Because of a
technical error, three 20-J electric shocks were delivered
without increasing the energy level in the intended fashion in
one control dog. Otherwise, the maximal number of shocks
required for initial defibrillation in survivors was two in both
study groups. Accordingly, the maximal energy level required
for initial defibrillation in survivors was 30 J in both study
Heart Rate
(heatsimin)
LVEDP
(mm Hg)
Normalized
FDSL
Peak
LVSP
(mm Hg)
Developed
LVSP
(mm Hg)
Peak +dPldt
(mm Hgds)
Peak -dpidt
(mm Hgn)
Mean
AuP
(mm Hg)
Mean
RAP
(nun Hg)
Baseline
Control group (n - 11) 143 + 20
8-3 1 .00 +_ 0 .00 124 * 22 116 - 20 2,708 ; 640 -2,727
.
943 113 '. " 5 - 4
Propranolol group (n = 11)
161 ± 3
1
* 5--4 1 .0'' 0 .0 123 ± 18 117 17 2,879 •* 682 -2,835 ± 810 110 +_ 18 11+6
After propranolol
('on~ :ol group (n - 11) 148 t 18
8 ± 2 1 .00 ±0.01 123 ± 19 116 ± 19 2,680 } 60i -2,711 ± 855
5 + 4
109 ± 20
Propranolul group (n = 11) 136 ± 26t
7 ± 4t 1 .03 ± 0 .021 116 Y 16t INS "_° 10 1,828 } 25 It 46fit• 10$ ± Ifii
7 ± 67
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Figure 1. Mean release phase aortic-right atrial pressure differences
as a function of time during the 5-min period of cardiopulmonary
resuscitation (CPR) . Control = dogs given epinephrine during resus-
citation without propranolol pretreatment ; Propranolol = dogs pre-
treated with propranolol and then given epinephrine during resuscita-
tion .
groups . Three of the six survivors in the control group required
an additional electrical shock after initial defibrillation as a
result of recurrent ventricular fibrillation . Ventricular fibrilla-
tion did not recur in any of the nine survivors in the proprano-
lol group.
Postresuscitation ver+tricular function . Post resuscitation
pressures and segment lengths in successfully resuscitated
animals are compared with the second set of prearrest values
in the same animals (obtained shortly before induction of
ventricular fibrillation in both study groups and after pro-
pranolol administration in the propranolol group) in Table 2
and Figure 3. One dog in the propranolol group died shortly
after successful defibrillation of an intrathoracic hemorrhage
(thought to have been caused by postresuscitation catheter
Table 2. Measurements in Successfully Defibrillated Dogs
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CPR Time (min)
Figure 2. Mean release phase aortic and right atria[ pressures as a
function of time during the 5-min period of cardiopulmonary resusci-
tation (CPR). Study groups as in Figure 1 .
manipulation) and could not be included in these analyses .
Spontaneous postresuscitation left ventricular performance
was depressed below prearrest levels in both study groups . For
example, in the propranolol group, peak positive left ventric-
ular dP/dt averaged 1,219 ± 137 mm Hg/s 15 min after
defibrillation compared with 1,768 ± 263 mm Hg/s after
propranolol administration under prearrest conditions (p <
0.05), whereas left ventricular end-diastolic pressure and nor-
malized end-diastolic segment length were unchanged (Fig . 3) .
However, peak and developed left ventricular systolic pres-
sures, left ventricular end-diastolic pressure, peak +dP/dt,
peak -dP/dt, mean aortic and right atrial pressures and
normalized left ventricular end-diastolic segment lengths did
not differ significantly between the two study groups when
measured either 5 or 15 min after CPR. When survivors in the
control group were given propranolol after the 15-min post-
60-
• E
*n = 5 ; otherwise n = 6 in the control groep and n =
8 in the propranolol group.
t p < 0
.05
versus prearrest. $p < 0.05 versus postresuscitation measurements
--15 min after defibrillation. §p < 0.05 versus control group
. Data presented are mean value ± SD . Only the second set of prearrest measurements
(i,e., those obtained
after propranolol administration in the propranolol group) are listed . Post-CPR 5
(Post-CPR 15) = measurements made --5 (15) min after defibrillation
; Post-CPR
20 = measurements made --20 min after defibrillation and after propranolol administration in the control group
. Other abbreviations as in Table 1 .
Prearrcst
Control group 154 ± 15 7 ± 2 0.99 ± 0.00 111 ± 13 104 13 2,345 ± 608
-2,182 ± 654 95 ± 10 6 ± 5
Propranolol group 135 ± 26 7 ± 5 1 .02 ± 0.01 115 ± 17 108 ± 15
1,768 "- 263 -2,301 ± 452 105
± 17 7 ± 7
Post-CPR 5
Control group* 140 ± 29 9 ± 2 1 .04 ± 0.07 76 ± 34 67 ± 32
-866 ± 624 53 ± 21 8
± 6
1,092
± 470
Propranolol group 131 ± 24 7 ± 4 1 .03 ± 0.08 84 ± 16t 77 ± 13$
1,098 ± 275t -1,119 ± 325$
64 ± 9t 4 ± 4t
Post-CPR 15
Control group 158 ± 26 7 ± 2 1 .03 ± 0.08
84 ± 20 77 ± 20 1,228 ± 327
-1,364 . 507 73 ± 13
5 ± 5
Propranolol group 135 ± 27 6 ± 3 1 .03 ± 0.07 93 ± 8t 87 ± 7t
1,219 ± 137$ -1,546 2751
81 ± 10t 3 ± 5t
Post-CPR 20
Control group 118 ± 20$ 10 ± 4$ 1 .09 ± 0.07$ 73 ± 23
63 ± 21a,: 750 ± 279t
-820 ± 418$ 66 ± 23
8 ± 7$
Propranolol group 135 ± 25 7 ± 3 1 .03 ± 0.07
96 ± 8t 90
± 7t§
1,271
± 125t§ -1,713 ± 252t§
85 ± 10t 3 ± 5t
Peak Developed Mean Mean
Heart Rate LVEDP Normalized LVSP LVSP Peak +dPldt Peak -dP/dt
AoP RAP
(heats/min) (mm Fig) EDSL (mm Hg) (mm Hg) (mm Hg/s) (mm Hg/s)
(mm Hg) (mm Hg)
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C
Fivre 3. Ilem(xlvnamic measurements before and 5 . IS and 20 min
after cardiopulmonary resuscitation (CPR) in successfully defibrillated
dogs. Only the second set of prearrest measurements (i .e . . those
obtained after propranolol administration in the propranolol group)
are shown. For clarity, standard deviations arc listed in Table 2 but are
not shown here . A. Peak left ventricular systolic pressure (LVSP) . B.
Developed left ventricular systolic pressure. C, Peak positive first
derivative of left ventricular pressure (+dP/dt) . D . Peak negative first
derivative of left ventricular pressure (-dP/dt1, E, Left ventricular
end-diastolic pressure (LVEDP) . F. Left ventricular end-diastolic
segment length (EDSL) .
defibrillation measurements to eliminate compensatory sym-
pathetic stimulation of the heart, the developed left ventricular
systolic pressure and peak +dP/dt were significantly lower
despite trends toward higher left ventricular end-diastolic
pressure and normalized end-diastolic segment length com-
.IAC(' Vol . 24. No. S
September 1944 -S114-12
pared with the propranolol group . In addition, peak -dP/dt
was significantly greater (i .e . . more negative) in the proprano-
lol group.
Peak positive dP/dt-normalized end-diastolic segment
length relations are summarized in Figure 4 . The data from
each relation illustrated were well characterized by linear
equations (r > 0.92 in all cases) . The two relations obtained
during separate vena caval occlusions under prearrest condi-
tions in the control group were similar to each other and to the
initial prearrest relation in the propranolol group (obtained
before propranolol administration) . Propranolol administra-
tion under prearrest conditions had the expected negative
inotropic effect of shifting this relation down and to the right .
The relations obtained 15 min after successful defibrillation
were similar in the two study groups and were shifted rightward
from prearrest relations in both groups . Vena caval occlusion
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Figure 4. Peak positive first derivative of left ventricular pressure
(+dP/dt)-normalized end-diastolic segment length (EDSL) relations
before and 15 min after cardiopulmonary resuscitation (CPR) in
successfully defibrillated dogs. Control Prearrest I and 2 = two sets of
measurements made under prearresi conditions in the control group:
Propranolol Prearrest I and 2 = prearrest measurements mau . . before
and after propranolol administration, respectively, in the propraanolol
group; Control and Propranolol Post-CPR 15 = measurements made
-15 min after defibrillation in the control and propranolol grouts,
respectively.
had little or no effect on left ventricular pressures and segment
lengths after propranolol administration in survivors in the
control group. Therefore, positive dP/dt could not he mea-
sured over a range of loading conditions under the final study
condition in this group . However, the single peak positive
dP/dt-end-diastolic segment length point present under these
conditions was significantly below and to the right of the full
peak positive dP/dt-normalized end-diastolic segment length
relation obtained in the propranolol group 20 min after
defibrillation (Fig. 5), indicating more severe left ventricular
dysfunction in the control group .
Weights, hematocrits and blood gases. Body weight did not
differ significantly between study groups (20.9 ± 2 .2 vs. 20.6
1 .8 kg). Hematocrits or blood gas analyses, or both, were not
obtained under all conditions in four dogs . Based on available
data, there were no significant differences between groups
before, during or after cardiopulmonary resuscitation with
regard to hematocrit or arterial pH or Paco 2 (Table 3).
Arterial partial pressure of oxygen (Pao,) was significantly
higher during and tended to he lower 5 min after CPR in the
propranolol group (Table 3) .
Discussion
Clinical experience suggests that epinephrine is beneficial
during CPR despite evidence that it fails to improve (and may
adversely affect) the balance between myocardial oxygen sup-
ply and demand during ventricular fibrillation (2,14) . This
clinical experience is supported by experimental evidence that
epinephrine increases coronary and cerebral perfusion pres-
sures and flow during resuscitation (2,8,11-14) and the likeli-
DITCHLY ET AL
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Figure 5 . Peak positive first derivative of left ventricular pressure
(+dP/dt)-notmalizcd end-diastolic segment length
(EDSL) relations
obtained -20 min after cardiopulmonary resuscitation and after
propranolol administration in the control group . Because vena caval
occlusion had little or no effect on left ventricular pressures and
segment lengths after propranolol administration in the control group.
only a single point is shown for this group . Dashed lines represent the
95ciconfidence intervals . Study groups as in Figure I .
hood of successful defibrillation (8,11-13,20) . In addition, it is
well known that beta-adrencrgic blocking agents have impor-
tant negative inotropic effects, particularly under conditions in
which ventricular performance is enhanced by catecholaminc
stimulation . Therefore, one might think that beta-adrenergic
blockade would decrease the likelihood of successful resusci-
tation from ventricular fibrillation and have a major adversL
effect on post resuscitation ventricular function .
Alpha- versus beta-adrenergic effects. We challenged this
concept for several reasons. First, epinephrine's efficacy during
CPR results primarily from its alpha-adrenergic effects (8) . In
an early evaluation of drugs used during CPR, Redding and
Pearson (20) found that the peripheral vasoconstrictors epi-
nephrine, phenylephrine, mctaraminol and methoxamine were
comparably effective in facilitating restoration of a spontane-
ous circulation after a 5-min period of circulatory arrest
induced by asphyxia (20) . The latter three drugs have predom-
inantly alpha-adrenergic effects . Likewise, in animals with
ventricular fibrillation, defibrillation rates were comparable in
dogs treated with epinephrine and phenylephrine (20) . Subse-
quent studies have yielded conflicting results (12,13,21-26),
with some investigators concluding that epinephrine is superior
to phenylephrine and methoxamine (12,13,21) and others
finding no significant differences between these agents during
experimental (22-24) or clinical resuscitation (25,26) . This
issue deserves further investigation . However, available evi-
dence suggests that epinephrine's effects on vital organ perfu-
sion pressures and flow during CPR are due to peripheral
vasoconstriction (8) and that stimulation of alpha-adrenergic
receptors is more important than stimulation of beta-
adrenergic receptors, at least during resuscitation from asphyx-
ial arrest (27,28) .
Furthermore, the fact that beta-adrenergic stimulation in-
Control
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Table 3
. Hematocrit and Arterial Blood Gas Measurements
creases myocardial oxygen consumption during ventricular
fibrillation (29) has important implications with respect to both
pharmacologic interventions during CPR and the intense
endogenous sympathetic activation characteristic of cardiovas-
cular collapse (10,30) . Myocardial oxygen consumption during
CPR ordinarily is limited by low levels of oxygen delivery
(13,31). However, when coronary flow is maintained artificially
at prearrest levels, myocardial oxygen consumption during
ventricular fibrillation and CPR is comparable to that of a
beating heart working under physiologic loading conditions
and can be reduced -.50% by beta-blockade (10) . With the
exception of a study by Halperin et al . (32), in which the
method of chest compression sometimes caused severe lung
and liver trauma, we are not aware of any reported studies in
which coronary blood flow was maintained at prearrest levels
during experimental CPR, regardless of the resuscitation tech-
nique or the type or dose of pharmacologic intervention
(1-9,11-13,32-35).
Vasoconstrictors, Thus, myocardial ischemia during CPR
results from a combination of low levels of coronary blood flow
and relatively high myocardial oxygen requirements as a result
of intense sympathetic stimulation of the heart by endogenous
catecholamines. Epinephrine and other vasoconstrictors in-
crease coronary blood flow during CPR, but there is reason to
doubt that vasoconstrictors alone can improve the balance
between myocardial oxygen supply and demand in this setting .
Brown et al. (13) reported that large doses of epinephrine
decrease the ratio of myocardial oxygen consumption to oxy-
gen delivery during CPR when administered after a 10-min
period of circulatory arrest and 3 min of CPR . This conclusion
depends on analyses of arterial and coronary sinus blood
samples obtained --2 min after drug administration . It is
possible that epinephrine has less of an effect on myocardial
oxygen consumption after prolonged periods of ischemia be-
cause of decreased myocardial adrenergic responsiveness or a
'n = 10 . tp < 0 .115 versus control group . # = 5 . Data presented are mean value
t SD. CPR = cardiopulmonary
resuscitation ; Paco, (Pao_) = arterial partial pressure of carbon dioxide (oxygen) .
JACC Vol. 24, No. 3
September 1994 :804-12
reduction in the heart's maximal capacity for oxygen utiliza-
tion. Alternatively, these findings may have resulted from
sampling before epinephrine's metabolic effects were fully
developed. In previous studies (2,14) in which myocardial
adenosine triphosphate (ATP) and lactate concentrations were
examined in biopsy specimens obtained immediately after
10 min of resuscitation begun immediately after the onset of
ventricular fibrillation, we found no evidence of metabolic
improvement when moderate doses of epinephrine were ad-
ministered (2) and evidence of more profound oxygen deple-
tion (i .e ., higher lactate concentrations and a trend toward
lower ATP concentrations) when large doses of epinephrine
were administered during CPR (14) . These findings do not
exclude the possibility that epinephrine could have a net
beneficial effect on myocardial oxygenation during CPR under
some circumstances, but they do demonstrate epinephrine's
potential adverse effects .
It is logical to think that a relatively pure alpha-adrenergic
agent would be more likely than epinephrine to improve the
balance between myocardial oxygen supply and demand during
CPR. In support of this concept, Livesay et al . (36) found that
methoxamine lacked epinephrine's adverse effects on myocar-
dial oxygen consumption during ventricular fibrillation when
the two drugs were administered in equipressor doses during
cardiopulmonary bypass. Likewise, in an isolated heart prepa-
ration in which coronary perfusion pressure was reduced
during ventricular fibrillation to simulate conditions present
during CPR, Midei et al . (37) found that myocardial oxygen
consumption was increased more by epinephrine than by a
tenfold higher dose of phenylephrine. However, Btown et al .
(12,13) reported that both phenylephrine and methoxamine
are less effective than large doses of epinephrine in promoting
coronary blood flow during CPR, possibly because of differ-
ences in alpha-subtype agonist activity. Furthermore, although
we recently found (14) that large doses of phenylephrine
Hematocrit
(%) pH
Pao,
(mm Hg)
Paco.
(mm Hg)
Prearrest (n = 11)
Control group 32 ± 3 7.40 ± 0.03 411± 108
39 '_ 3
Propranolol group 32 ± 5 7.40±0.03
450±46 41±3
CPR (n = 11)
Control group 44 ± 8' 7.52 ± 0.14 260 ± 144 23 ± I 1
Propranolol group 44 ± 9' 7
.43 ± 0.13 294 ± 17 It 31 ± 14
Post-CPR 5
Control group (n = 5) 52 * 5 7.30±0.08 192±83
42± 10
Propranolol group (n = 8) 51 t 8
7 .22 ± 0.06 86 ± 26 55 *_ 8
Post-CPR 15
Control group (n = 6) 51 ± 4 7 .21 ± 0.06 16 ; ± 59
50 ± 7
Propranolol group (n = 8) 49 ± 6
7.26 ±0,07 149t 67 49t 10
Post-CPR 20
Control group (n = 4) 50 t 4t 7.22±0.07 144±39 4379
Propranolol group (n = 8) 47 ± 6 7 .28 ± 0.06 156 . 62
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(0.4 mglkg) and epinephrine (0.2 mg/kg) had virtually identical
effects on coronary perfusion pressure during ('PR, phenyleph-
rine administration did not appear to improve myocardial
oxygenation. Postresuscitation myocardial ATP concentral ions
did not differ, andpoxtrrsu»ciiutinnmyocardial lactate concen-
trations were higher in dogs given phenylephrine compared
with concentrations in untreated animals (14) . Phenylephrine
may have increased myocardial oxygen consumption directly or
decreased coronary flow by increasing coronary resistance-we
did not measure coronary flow in those studies, although large
doses of pbemJnphrinn have been reported (13) to increase
coronary blood flow in other CPR models . It is also possible
that the beneficial hemodynamic effects of phenylephrinc were
offset by enhanced delivery of endogenous catecholamines to
the heart. Ili fact, when one considers the extremely high
concentrations of circulating endogenous catecholamines
present during CPR, it is difficult to envision how eVen a pure
vasoconstrictor could increase coronary blood flow during
CPR without increasing beta-adrenergic stimulation of (lie
heart. For this reason, we believe that pharmacologic interven-
tions am unlikely to significantly improve the balance between
myocardial oxygen supply and demand during [`PR unless they
reduce myocardial oxygen requirements.
a
Bw{m'mdnemergic blockade . The results of the present study
suggest that beta-adrenergic blockade can reduce myocardial
injury during CPR without compromising the likelihood of
successful defibrillation or spontaneous postresuscitation left
ventricular function, After a 5-min period of CPR begun
immediately after the onset of ventricular fibrillation. we were
able to defibrillate 9 of \l dogs pretreated with propranolol
nd given epinephrine during ('PR compared with 6 of \ \dogs
given epinephrine alone . Although these observations lacked
sufficient stndsdcol power to allow us to conclude that pro'
pmno\n\ is beneficial . i t certainly was not detrimental
. This
finding is consistent with the observation that beta-adrenergic
stimulation is not essential for successful resuscitation from
osysto\ioor houdycurdic circulatory arrest induced by asphyxia
(27,28). We also found that adeqliate left ventricular systolic
function can be maintained during the immediate pmdrcxuxci'
tobon period in the presence , if beta-adrenergic blockade .
There were no significant differences in any of the measured
indexes of left ventricular performance between control and
propranolol-pretreated animals either 5 or 15 min after suc-
cessful defibrillation. On the basis of observations in an
isolated heart model, Midei et al . (37) concluded that
beta'
stimulation in the presence of low coronary perfu-
sion pressure can increase myocurdial ischemic injury during
ventricular fibrillation and lead to depressed myocardial per-
formance in the early postdc fibrillation period. Our findings
support this concept, as evidenced by the fact that survivors in
the control group had more severely depressed left ventricular
function than propranolol-pretreated animals when sympa-
thetic stimulation was eliminated after resuscitation (Table 2,
Fig. 5) .
We began investigating the effects of propranolol during
CPR because we believed that beta-adrenergic blockade would
have xmajor c5ec on mymnrdal oxygen requirements in this
setting. Our previous experimental observations support this
concept (!K!4)umio!\hoxuhocJNno r mcusunnlyocavdiue
oxygen consumption in the present Study, we presume that
piropmrithil was beneficial (luring CPR, at least in part because
it reduced myocardial oxygen deniands . In addition, this is the
second study in which we have found that nonsc/cchvchc<u'
xdrrncqgic blockade increases coronary perfusion pressure
during CPR (14) . suggesting that it also may increase coronary
blood flovv. This effect appears to be substantial in magnitude
(Fig. l) and suggests that hc\o'odnrncrAic blockade can en-
hance vasoconstriction during CPR by allowing unopposed
alpha-adrenergic stimulation of resistance vessels . Therefore it
may be that nonselective bela-adrenergic blockade improves
the balance between myocxrdixl oxygen supply and demand
during CPR both by reducing myocardial oxygen requirements
and by increasing oxygen delivery to the heart .
However, pnpmno}ol pretreatment was not completcly
protective in these mudics. Posnxumhxhon left veiaricular
function was moderately depressed relative to posIpropranolol
measurements before CPR . Although it is possible that tile
large doses of propratiolol used did not result in complete
beta-adrenergic blockade, we found previously (10) that half of
this dose reduces myocardial oxygen requirements during
resuscitation by 50% . A more likely possibdity is that coro-
nary blood flow during CPR was not adequate to meet
myocardial oxygen demands during ventricular fibrillation,
even in tile absence of beta -adrenergic stimulation .
Study limitations . Finally. it is important (o emphasize that
we did not study (lie effects of beta-blocker administration
during CPR . We administered propranolol before CPR to
allow a comparison of functional indexes beforeandafter CPR
in tile same animals without different levels of sympathetic
stimulation . Rnwcvc : it is likely that prop mnok\ xdminkUna'
hoo dairig CPR would have had similar effects because it
improves the balance between myocardial oxygen supply and
demand during CPR when administered after the onset of
ventricular fibrillation (14) . Additional studies will be neces-
sary to confirm that this is the case . A further consideration is
the fact that we initiated CPR immediately after the (inset of
ventricular fibrillation rather than after a period of circulatory
arrest, as Would be encountered in most clinical circumstances.
This study design was chosen specifically to eliminate the
confounding effects of antecedent ischemic injury before CPR
on postresuscitation left vcntricular function and to maximize
the likelihood of successful resuscitation
. It remains to be
determined whether and in what way the effects of hc{x-
udoncr&ich!nckxJc during CPR are influenced by antecedent
periods of circulatory arrest . Furthermore, we have no way of
knowing whether heta-adrenergic blockade would have similar
beneficial effects durkig CPR in the presence of significant
preexisting left ventricular dys[unchon . However, it seems
entirely possible that the importance of any depressant effects
under such circumstances would be more than offset by a
reduction in myocondiul injury during CPR, particularly if
protection during CPR can be obtained with short-acting
812
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beta-blockers . At this point, the case for beta-adrenergic
blockade during CPR is not sufficiently strong to warrant trials
in human subjects, particularly in view of the established
efficacy of epinephrine . However, in view of these initial
results, we believe that the effects of beta-blockade during
CPR deserve further evaluation.
We thank Stephen Bell and David Robbins for expert technical assistance and
Nancy Pcrrinc our preparing the manuscript .
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